Full name
EUROPEJSKI INSTYTUT BIOMEDYCZNY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
EUROPEJSKI INSTYTUT BIOMEDYCZNY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. BARTYCKA 63A / 6, 00-716 WARSZAWA
TAX ID5213950320
Rate company:
EUROPEJSKI INSTYTUT BIOMEDYCZNY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5213950320
KRS0000938236
Share capital250,000.00 zł
address
UL. BARTYCKA 63A / 6, 00-716 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5213950320
REGON
520772830
KRS
0000938236
Legal form
limited liability company
Register Address
UL. BARTYCKA 63A / 6, 00-716 WARSZAWA
Date of registration in KRS
2021-12-20
Date of commencement of economic activity
2021-12-20
Act signature
WA.XIV NS-REJ.KRS/10796/22/17/ADE
Pkd codes
72.11.Z - Scientific research and development activities
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72 - Scientific research and development activities
72.1 - Scientific research and development in natural and technical sciences
72.19.Z - Scientific research and development activities
75.00.Z - Veterinary activities
Payer VAT status
Active
Vat list bank account(s)
PL28 1050 1025 1000 0090 8177 2510 
PL83 1050 1025 1000 0090 8147 0917 PL39 1050 1025 1000 0090 8147 0933 PL17 1050 1025 1000 0090 8147 0941 PL06 1050 1025 1000 0024 8079 2635 Show more bank accounts from VAT list (2)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0 | 2,7 | 4,7 | 73,8 |
Gross profit (loss) | 0 | 2,7 | 4,8 | 73,9 |
EBITDA | 0 | 3 | 4,8 | 57,7 |
Short time liabilities | 0 | 0,4 | 0,3 | -29,8 |
Other operating costs | 0 | 0 | 0 | -100 |
Equity capital | 0 | 2,8 | 7,1 | 156,7 |
Operating profit (EBIT) | 0 | 2,7 | 4,7 | 73,7 |
Assets | 0 | 3,2 | 7,4 | 132,5 |
Net profit (loss) | 0 | 2,2 | 3,8 | 73,3 |
Cash | 0 | 2,8 | 6,6 | 135,9 |
Liabilities and provisions for liabilities | 0 | 0,4 | 0,3 | -29,8 |
Net income from sale | 0 | 6 | 9,7 | 62,4 |
Working assets | 0 | 3,1 | 7,1 | 132,1 |
Other income costs | 0 | 0 | 0 | -8,9 |
Depreciation | 0 | 0,3 | 0,1 | -83,1 |
% | % | % | p.p. | |
Profitability of capital | 79,7 | 53,8 | -25,9 | |
Equity capital to total assets | 87 | 96,1 | 9,1 | |
Gross profit margin | 46 | 49,2 | 3,2 | |
EBITDA Margin | 51 | 49,5 | -1,5 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 25 | 11 | -14 |
Current financial liquidity indicator | 7.362612247467041 | 24.339685440063477 | 16,9 | |
Net dept to EBITDA | -0.9189044833183289 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.